Actinogen Medical Limited (ASX:ACW)
Australia
· Delayed Price · Currency is AUD 0.0420
+0.0010 (2.44%)
At close: Mar 6, 2026
Actinogen Medical Revenue
Actinogen Medical had revenue of 1.87M AUD in the half year ending December 31, 2025, with 106.17% growth. This brings the company's revenue in the last twelve months to 7.36M, down -18.38% year-over-year. In the fiscal year ending June 30, 2025, Actinogen Medical had annual revenue of 5.49M, down -44.73%.
Revenue (ttm)
7.36M
Revenue Growth
-18.38%
P/S Ratio
20.39
Revenue / Employee
1.23M
Employees
6
Market Cap
150.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.49M | -4.44M | -44.73% |
| Jun 30, 2024 | 9.93M | 5.04M | 103.18% |
| Jun 30, 2023 | 4.89M | 1.25M | 34.28% |
| Jun 30, 2022 | 3.64M | 1.66M | 83.47% |
| Jun 30, 2021 | 1.98M | -1.53M | -43.58% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recce Pharmaceuticals | 974.56K |
| Starpharma Holdings | 14.58M |
| Botanix Pharmaceuticals | 21.92M |
| Island Pharmaceuticals | 62.85K |
| Paradigm Biopharmaceuticals | 8.45K |
| Tetratherix | 2.00M |
| Arovella Therapeutics | 3.21M |
| Orthocell | 9.33M |